{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T13:50:50Z","timestamp":1791121850203,"version":"4.1.0"},"reference-count":51,"publisher":"The Endocrine Society","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2004,2,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>We completed the mapping of a cutaneous CRH signaling system in two species with widely different determinants of skin functions, humans and mice. In human skin, the CRH receptor (CRH-R) 1 was expressed in all major cellular populations of epidermis, dermis, and subcutis with CRH-R1\u03b1 being the most prevalent isoform. The CRH-R2 gene was expressed solely in hair follicle keratinocytes and papilla fibroblasts, whereas CRH-R2 antigen was localized predominantly in hair follicles, sebaceous and eccrine glands, muscle and blood vessels. In mouse skin, the CRH-R2 gene and protein were widely expressed in all cutaneous compartments and in cultured normal and malignant melanocytes. CRH-binding protein mRNA was present in dermal fibroblasts, melanoma cells, and sc fat of human skin and undetectable in mouse skin. The urocortin II gene was expressed equally in mouse and human skin. Taken together with our previous investigations, the present studies document the preferential expression of CRH-R1 in human skin, which mirrors CRH-R2 expression patterns in human and mouse skin. They are likely reflecting different functional activities of human and mouse skin. The adnexal location of CRH-R2 suggests a role for the receptor in hair growth. The differential interspecies CRH signaling expression pattern probably reflects adaptation to species-specific skin function determinants.<\/jats:p>","DOI":"10.1210\/en.2003-0851","type":"journal-article","created":{"date-parts":[[2003,11,11]],"date-time":"2003-11-11T01:13:38Z","timestamp":1068513218000},"page":"941-950","source":"Crossref","is-referenced-by-count":154,"title":["Differential Expression of a Cutaneous Corticotropin-Releasing Hormone System"],"prefix":"10.1210","volume":"145","author":[{"given":"Andrzej","family":"Slominski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Pisarchik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Desmond J.","family":"Tobin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph E.","family":"Mazurkiewicz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacobo","family":"Wortsman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","reference":[{"key":"2020071613170808600_R1","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S1043-2760(98)00079-4","article-title":"Corticotropin releasing hormone, receptor regulation and the stress response.","volume":"9","author":"Aguilera","year":"1998","journal-title":"Trends Endocrinol Metab"},{"key":"2020071613170808600_R2","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0165-6147(02)01946-6","article-title":"The CRF peptide family and their receptors: yet more partners discovered.","volume":"23","author":"Dautzenberg","year":"2002","journal-title":"Trends Pharmacol Sci"},{"key":"2020071613170808600_R3","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/S1043-2760(02)00670-7","article-title":"Functional characteristics of CRH receptors and potential clinical applications of CRH-receptor antagonists.","volume":"13","author":"Grammatopoulos","year":"2002","journal-title":"Trends Endocrinol Metab"},{"key":"2020071613170808600_R4","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/j.1749-6632.1999.tb08687.x","article-title":"Corticotropin releasing factor receptors and their ligand family.","volume":"885","author":"Perrin","year":"1999","journal-title":"Ann NY Acad Sci"},{"key":"2020071613170808600_R5","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1113\/eph8602183","article-title":"Corticotrophin releasing hormone: its potential for a role in human myometrium.","volume":"86","author":"Linton","year":"2001","journal-title":"Exp Physiol"},{"key":"2020071613170808600_R6","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1152\/physrev.2000.80.3.979","article-title":"Corticotropin releasing hormone and proopiomelanocortin involvement in the cutaneous response to stress.","volume":"80","author":"Slominski","year":"2000","journal-title":"Physiol Rev"},{"key":"2020071613170808600_R7","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1096\/fj.00-0850rev","article-title":"Cutaneous expression of corticotropin-releasing hormone (CRH), urocortin, and CRH receptors.","volume":"15","author":"Slominski","year":"2001","journal-title":"FASEB J"},{"key":"2020071613170808600_R8","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/0165-6147(96)81594-X","article-title":"Corticotropin-releasing factor receptors: from molecular biology to drug design.","volume":"17","author":"Chalmers","year":"1996","journal-title":"Trends Pharmacol Sci"},{"key":"2020071613170808600_R9","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.1073\/pnas.051626398","article-title":"Urocortin II: a member of the corticotropin-releasing factor (CRF) neuropeptide family that is selectively bound by type 2 CRF receptors.","volume":"98","author":"Reyes","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"2020071613170808600_R10","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/87936","article-title":"Human stresscopin and stresscopin-related peptide are selective ligands for the corticotropin-releasing hormone receptor.","volume":"7","author":"Hsu","year":"2001","journal-title":"Nat Med"},{"key":"2020071613170808600_R11","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1677\/joe.0.1750089","article-title":"Corticotropin-releasing hormone-binding protein: biochemistry and function from fishes to mammals.","volume":"175","author":"Seasholtz","year":"2002","journal-title":"J Endocrinol"},{"key":"2020071613170808600_R12","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/349423a0","article-title":"Cloning and characterization of the cDNAs for human and rat corticotropin releasing factor-binding proteins.","volume":"349","author":"Potter","year":"1991","journal-title":"Nature"},{"key":"2020071613170808600_R13","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0378-1119(98)00322-9","article-title":"The genomic organization of the human corticotropin-releasing factor type-1 receptor.","volume":"219","author":"Sakai","year":"1998","journal-title":"Gene"},{"key":"2020071613170808600_R14","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1210\/mend.13.12.0391","article-title":"A novel spliced variant of the type 1 corticotropin-releasing hormone receptor with a deletion in the seventh transmembrane domain present in the human pregnant term myometrium and fetal membranes.","volume":"13","author":"Grammatopoulos","year":"1999","journal-title":"Mol Endocrinol"},{"key":"2020071613170808600_R15","doi-asserted-by":"crossref","first-page":"2754","DOI":"10.1096\/fj.01-0487fje","article-title":"Alternative splicing of CRH-R1 receptors in human and mouse skin: identification of new variants and their differential expression.","volume":"15","author":"Pisarchik","year":"2001","journal-title":"FASEB J"},{"key":"2020071613170808600_R16","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1210\/me.2002-0302","article-title":"Regulation of corticotropin-releasing hormone type 2 receptors by multiple promoters and alternative splicing: identification of multiple splice variants.","volume":"17","author":"Catalano","year":"2003","journal-title":"Mol Endocrinol"},{"key":"2020071613170808600_R17","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1210\/endo.137.1.8536644","article-title":"Cloning and characterization of he human corticotropin-releasing factor-2 receptor complementary deoxyrubonucleic acid.","volume":"137","author":"Liaw","year":"1996","journal-title":"Endocrinology"},{"key":"2020071613170808600_R18","first-page":"1077","article-title":"Molecular identification and analysis of a novel human corticotropin-releasing factor (CRF) receptor: The CRF2g receptor.","volume":"12","author":"Kostich","year":"1998","journal-title":"Mol Endocrinol"},{"key":"2020071613170808600_R19","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0167-4781(97)00047-X","article-title":"A new functional isoform of the human CRF2 receptor for corticotropin-releasing factor.","volume":"1352","author":"Valdenaire","year":"1997","journal-title":"Biochim Biophys Acta"},{"key":"2020071613170808600_R20","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.1096\/fj.01-0254fje","article-title":"In situ expression of corticotropin-releasing hormone (CRH) and proopiomelanocortin (POMC) genes in human skin.","volume":"15","author":"Kono","year":"2001","journal-title":"FASEB J"},{"key":"2020071613170808600_R21","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1290\/1071-2690(2001)037<0050:PEOCRH>2.0.CO;2","article-title":"Pleiotropic effects of corticotropin releasing hormone (CRH) on normal human keratinocytes.","volume":"37","author":"Quevedo","year":"2001","journal-title":"In Vitro Cell Dev Biol"},{"key":"2020071613170808600_R22","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/j.1749-6632.1999.tb08686.x","article-title":"Cutaneous expression of CRH and CRH-R: is there a \u201cskin stress system?\u201d","volume":"885","author":"Slominski","year":"1999","journal-title":"Ann NY Acad Sci"},{"key":"2020071613170808600_R23","first-page":"1020","article-title":"Characterization of corticotropin releasing hormone (CRH) in human skin.","volume":"83","author":"Slominski","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613170808600_R24","first-page":"815","article-title":"The skin produces urocortin.","volume":"85","author":"Slominski","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613170808600_R25","first-page":"3582","article-title":"Liquid chromatography-mass spectrometry detection of corticotropin-releasing hormone and proopiomelanocortin-derived peptides in human skin.","volume":"85","author":"Slominski","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613170808600_R26","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1046\/j.1523-1747.2002.01770.x","article-title":"Corticotropin releasing hormone receptor type 1: molecular cloning and investigation of alternative splicing in the hamster skin.","volume":"118","author":"Pisarchik","year":"2002","journal-title":"J Invest Derm"},{"key":"2020071613170808600_R27","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1111\/1523-1747.ep12382606","article-title":"Melanogenesis during the anagen-catagen-telogen transformation of the murine hair cycle.","volume":"102","author":"Slominski","year":"1994","journal-title":"J Invest Dermatol"},{"key":"2020071613170808600_R28","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1046\/j.1523-1747.2003.12242.x","article-title":"Regulation of human epidermal melanocye biology by \u03b2-endorphin.","volume":"120","author":"Kauser","year":"2003","journal-title":"J Invest Dermatol"},{"key":"2020071613170808600_R29","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/j.1600-0749.1996.tb00122.x","article-title":"Different populations of melanocytes are present in hair follicles and epidermis.","volume":"916","author":"Tobin","year":"1996","journal-title":"Pigment Cell Res"},{"key":"2020071613170808600_R30","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1600-0625.1998.tb00326.x","article-title":"Identification of \u03b2-endorphin, \u03b1-MSH and ACTH peptides in cultured human melanocytes, melanoma and squamous cell carcinoma cells.","volume":"7","author":"Slominski","year":"1988","journal-title":"Exp Dermatol"},{"key":"2020071613170808600_R31","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1007\/s11626-999-0093-6","article-title":"Modification of melanogenesis in cultured human melanoma cells.","volume":"35","author":"Slominski","year":"1999","journal-title":"In Vitro Cell Dev Biol"},{"key":"2020071613170808600_R32","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1046\/j.1523-1747.2003.12034.x","article-title":"Cutaneous metabolism of vitamin B-6.","volume":"120","author":"Coburn","year":"2003","journal-title":"J Invest Dermatol"},{"key":"2020071613170808600_R33","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1242\/jcs.89.3.287","article-title":"Positive regulation of melanin pigmentation by two key substrates of the melanogenic pathway: L-tyrosine and L-dopa.","volume":"89","author":"Slominski","year":"1988","journal-title":"J Cell Sci"},{"key":"2020071613170808600_R34","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1242\/jcs.92.4.551","article-title":"MSH inhibits growth in a line of amelanotic hamster melanoma cells and induces increases in cAMP levels and tyrosinase activity without inducing melanogenesis.","volume":"92","author":"Slominski","year":"1989","journal-title":"J Cell Sci"},{"key":"2020071613170808600_R35","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/1523-1747.ep12460928","article-title":"Pathology and ultrastructural characteristics of a hypomelanotic variant of transplantable hamster melanoma with high tyrosinase actiity.","volume":"89","author":"Bomirski","year":"1987","journal-title":"J Invest Derm"},{"key":"2020071613170808600_R36","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1046\/j.1365-2826.1996.04866.x","article-title":"Corticotrophin-releasing hormone receptor type 1: generation and characterization of polyclonal antipeptide antibodies and their localization in pituitary cells and cortical neurones in vitro.","volume":"8","author":"Castro","year":"1996","journal-title":"J Neuroendocrinol"},{"key":"2020071613170808600_R37","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1677\/joe.0.1560015","article-title":"Expression of corticotrophin-releasing hormone receptor mRNA and protein in the human myometrium.","volume":"156","author":"Rodriguez-Linares","year":"1998","journal-title":"J Endocrinol"},{"key":"2020071613170808600_R38","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1111\/j.1476-5381.1993.tb13490.x","article-title":"Relaxing actions of corticotropin-releasing factor on rat resistance arteries.","volume":"108","author":"Lei","year":"1993","journal-title":"Br J Pharmacol"},{"key":"2020071613170808600_R39","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/0014-2999(87)90766-7","article-title":"Binding of [125I]Tyr-corticotropin-releasing factor to rabbit aorta is reduced by removal of the endothelium.","volume":"135","author":"Dashwood","year":"1987","journal-title":"Eur J Pharmacol"},{"key":"2020071613170808600_R40","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/sj.bjp.0702261","article-title":"Studies of the role of endothelium-dependent nitric oxide release in the sustained vasodilator effects of corticotrophin releasing factor and sauvagine.","volume":"126","author":"Barker","year":"1999","journal-title":"Br J Pharmacol"},{"key":"2020071613170808600_R41","doi-asserted-by":"crossref","first-page":"7148","DOI":"10.1073\/pnas.102180999","article-title":"Corticotropin-releasing hormone: an autocrine hormone that promotes lipogenesis in human sebocytes.","volume":"99","author":"Zouboulis","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"2020071613170808600_R42","doi-asserted-by":"crossref","first-page":"4946","DOI":"10.1210\/endo.142.11.8507","article-title":"Regulation of the hypothalamic-pituitary-adrenocortical system in mice deficient for CRH receptors 1 and 2.","volume":"142","author":"Preil","year":"2001","journal-title":"Endocrinology"},{"key":"2020071613170808600_R43","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/S0896-6273(00)80491-2","article-title":"Corticotropin releasing factor receptor 1-deficient mice display decreased anxiety, impaired stress response, and aberrant neuroendocrine development.","volume":"20","author":"Smith","year":"1998","journal-title":"Neuron"},{"key":"2020071613170808600_R44","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1210\/en.2002-0117","article-title":"Role of corticotropin-releasing factor receptors type 1 and 2 in modulating the rat adrenocorticotropin response to stressors.","volume":"144","author":"Rivier","year":"2003","journal-title":"Endocrinology"},{"key":"2020071613170808600_R45","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0304-4165(95)00159-X","article-title":"The expression of proopiomelanocortin (POMC) and of corticotropin releasing hormone receptor (CRH-R) genes in mouse skin.","volume":"1289","author":"Slominski","year":"1996","journal-title":"Biochim Biophys Acta"},{"key":"2020071613170808600_R46","first-page":"287","article-title":"Hair cycle-dependent expression of corticotropin releasing factor (CRF) and CRF receptors (CRF-R) in murine skin.","volume":"12","author":"Roloff","year":"1998","journal-title":"FASEB J"},{"key":"2020071613170808600_R47","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/0014-5793(95)01090-2","article-title":"Proopiomelanocortin, corticotropin releasing hormone and corticotropin releasing hormone receptor genes are expressed in human skin.","volume":"374","author":"Slominski","year":"1995","journal-title":"FEBS Lett"},{"key":"2020071613170808600_R48","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1290\/1071-2690(2000)036<0309:PAIHVM>2.0.CO;2","article-title":"PIG3V, an immortalized human vitiligo melanocyte cell line, expresses dilated endoplasmic reticulum.","volume":"36","author":"LePoole","year":"2000","journal-title":"In Vitro Cell Dev Biol"},{"key":"2020071613170808600_R49","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1290\/1071-2690(2000)036<0211:CRHARP>2.0.CO;2","article-title":"Corticotropin releasing hormone (CRH) and related peptides can act as bioregulatory factors in human keratinocytes.","volume":"36","author":"Slominski","year":"2000","journal-title":"In Vitro Cell Dev Biol"},{"key":"2020071613170808600_R50","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/1523-1747.ep12482134","article-title":"Factors regulating growth and pigmentation of melanoma cells.","volume":"66","author":"Pawelek","year":"1976","journal-title":"J Invest Dermatol"},{"key":"2020071613170808600_R51","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1242\/jcs.98.2.135","article-title":"Colour genes, oncogenes and melanocyte differentiation.","volume":"98","author":"Bennett","year":"1991","journal-title":"J Cell Sci"}],"container-title":["Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/endo\/article-pdf\/145\/2\/941\/9026487\/endo0941.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/endo\/article-pdf\/145\/2\/941\/9026487\/endo0941.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,12]],"date-time":"2021-06-12T19:51:50Z","timestamp":1623527510000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/endo\/article\/145\/2\/941\/2500777"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,2,1]]},"references-count":51,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2004,2,1]]}},"URL":"https:\/\/doi.org\/10.1210\/en.2003-0851","relation":{},"ISSN":["0013-7227","1945-7170"],"issn-type":[{"value":"0013-7227","type":"print"},{"value":"1945-7170","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,2,1]]}}}